P32 による脳腫瘍のアイソトープ摂取量と組織学的所見について by MITANI, TETSUMI
TitleA study on Phosphorus Uptake of Brain Tumor by RadioactiveIsotope in Relation to Histological Findings
Author(s)MITANI, TETSUMI








A Study on Phosphorus Uptake of Brain Tumor by Radioactive 
Isotope in Relation to Histological Findings 
、 、??
TETSUMI MITANI 
From the l吋tSurgical Division, K、けtoUniversity Medic;i¥ School 
(Director : Prof. Dr. CHISATO • .¥RAK!) 
Received for Publication ¥1av 10町 1964
1 Introducion 
The prognosis of brain tumor has not been fully clarified yet owing to the facts that, 
it depends greatly on various conditions , e.ε. where the tumor originates in the brain 
and to which direction it is growing. On the other hand, the histological feature of the 
tumor not always accords to the clinical course・
Intracellular metabolism is generally increased in tumor tissues and phosphorus com-
pounds are known to play important roles in carbohydrates and nucleic acid metabolism, 
thus it will be easily presumable that phosphorus metabolism will be increased in tumor 
tissues in which a large growth activity is present. Such a tendency has been noted in 
human cancer tissue or in tumors of animals. Trials in which radioactive P32 has been 
used to determine the malignancy of tumors or to differentiate a malignant tumor from 
benign one, have been reported by many scholars: REDDY et al23>. applied P32 to human 
ovarian tumor, TUDWAY35> to intraocular tumor, NAKAYAMA21> to tumors of alimentary 
tract and again BAUER3> et al. used it to cutaneous tumors. ~II the above reporters ob-
served the higher concentration of isotope in malignant tumors than benign tumors or 
inflammatory lesions. However, the concentration in malignant tumor was not more than 
3 times as high as that of normal tissue taken as the control. 
SELVERSTOI\E10>3•>32>, on the other hand, reported far higher concentration of isotopes 
in brain tumors when P32 or !131 was administered to patients who had the brain tumor. 
Furthermore, some scholars noted that the rate of this concentration paralleled to the histo-
logical malignancy of tumor to a certain degree. However, these studies were not enough 
to substantiate their conclusion owing to the limited number of cases, unsatisfactory histo-
logical determination or the lacking of chemical analysis. The present study was made to 
inve只tigatethe manner of isotope uptake in details and compare this result to the histo-
logical picture and the clinical feature. Thus, P32 was広ivento patients of brain tumor 
with an idea to clarifv some nature of these tumors. 
2 Materials and methods 
Patients who were undergoing the operation for brain tumor were selected. About 
20 hours prior to the operation, 1.0 to '.2.0mc of P32 was injected intravenously or intra-
muscularly. Isotope used was obtained from Japan Isotope Association and P32 was con-
tained in dilute hydrochloric acid solution in the form of ortho-phosphoric acid. The 
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solution was sterilized and properly diluted with RINGER-LOCKE、ssolution. 
The tumor tissue and normal brain and muscle tissue obtained during the operativヒ
procedure, were minced on the ice cold glass plate, washed briefly in cold normal saline 
then excess fluid was removed. A portion was put into formalin fixative for the histo-
logical examination, and the other portion of 300mg to 1 OOOmg wet weight of tissue was 
weighed and transfered into ice cold ELVEHJEM-POTTER homogenizer. The tissue was 
homogenized with 6cc of 10% perchloric acid. Before homogenizing, necrotic and hemorrha-
gic portion or blood coagule were carefully removed and only homogenous and well pre-
served portion was selected. 
The homogenate was fractionated according to ScHNEIDER's22J 26J 29J 3"l method. Smce 
this method is simple and白 nbe completed relatively in short period of time, and it meets 
the necessity of radioactivity determination in short time so that only small amount of P32 
can be administered to patients to give the least harm to them. MOORE et aJ17l. have 
studied that, when P" was administered to the human body, it is concentrated in brain 
and brain tumor tissue in large amount within few hours then gradually released, but 
between 16 and 48 hours after the injection, the relatively constant P32 concentration was 
maintained in these tissues. The present experiment was scheduled to be completed during 
this stable period to minimize the effect of time factor because the time of obtaining the 
tissue could not be anticipated exactly since it depended on the progr白sof operative pro-
cedure. 
ScHNEIDER25J25J27J and DAVIDSON et al4>5l5l7J. have made detailed research on the 
contents of each fraction divided by the method above mentioned : The acid soluble frac-
tion contains phosphorus of phosphate mononucleotides, carbohydrate compounds and low 
molecule phosphate esters. The phospholipid fraction contains phosphorus in various com-
pounds such as cephaline, acetal phospholipids or inositol lipids. The nucleic acid fraction 
contains DNA, RNA and inositid phosphorus. The phosphoprotein fraction contains various 
kinds of phosphoprotein. 
The obtained homogenate was centrifuged in refrigerator, and the precipitate was again 
extracted with 4cc of ice cold 10% perchloric acid solution. Both supernatants were mixed 
together as the acid メolublefraction. '.'Jext the residue was extracted with 5cc of 80% 
ethanol then with 5cc of pure ethanol, and then 3 1 ethanol-ether mixture extraction for 
3 minutes was done 3 times in 70° C. All these supernatants were put together as the 
phospholipid fraction. The precipitate was put into 90°C bathing for 15 minutes with 
5cc of 5% perchloric acid. This was centrifuged and the precipitate was washed with 
5cc of 5% perchloric acid. These supernatants were mixed together as the nucleic acid 
fraction. 6cc of 2% NaOH aqueous solution was added to the final residue and this was 
put into boiling water for 10 minutes to complete the hydrolysis. The obtained solution 
is the phosphoprotein fraction. Each solution was put into calibrated test tube and the 
volume was corrected with each extracting solution so that the final volume of each fraction 
became lOcc acid soluble fraction, 25cc phospholipid fraction, lOcc nucleic acid fraction 
and 6cc phosphoprotein fraction respectively. 
2cc each of these samples were put into a small metal can and desiccated completely, 
then radioactivity of each sample was determined by GEIGER-MOLLER tube. (Mica window 
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type, B lB, SHIMAZU Co・） Iロthisprocedure, samples of the acid soluble fraction and 
the nucleic acid fraction were neutralized with a measured amount of ice cold 10% KC! 
solution. The supernatant was used for radioactivity determination. By this procedure, 
no radioactiYity was found in the precipitate and self absorption of each sample was les 
than 5% so that this error could be disregarded. Each determination was carried out for 
the enough period of time to bring down the error at most les than 10%. Usual coト
rection of background and decay was done so that obtained value of each fraction wil 
represent the count per minute, per gram of tissue at the time of operative removal of 
each tissue. 
The background count was fairly stable throughout this experiment and it ranged 
between 30 to 36 cpm. 
＼ピxt,a certain amount of each sample was ashed in micro-KJELDAHL frask with 0.8cc 
of 60% perchloric acid solution with heating at 180°C. Thus phosphorus in sample was 
turned into the inorganic form, then amount of phosphorus was determined by ALLEN's1> 
colorimetric method . The blue coloration was measured with electrophotometer by the 
absorption rate at 660m11. 0.5cc each sample of acid soluble and phospholipid fraction 
were used for this determination and l .Occ in the case of other fractions, because the 
formers contain a large amount of phosphorus. The obtained value was calculated into 
phosphorus amount per gram of fresh sample. Each determination was done in duplicated 
or triplicated samples and the mean value was taken. 
Tissues fixed in formalin were used for the histological preparation. Hemotoxylin-
eosin stain was done. Since the entire tissue utilized in this experiment was so small that 
weighed only 1.5 to 2.0g, it may be justifiable to presume that the portion used for chemical 
analysis and the one for histological examination may not differ greatly. However, in 
histological examination, when the tissue which was thought to be tumor tissue, did not 
contain tumor at al or contained it only partially or when the tissue taken as the normal 
tissue was invaded by tumor cels, such casどち were excluded from the study. 
Sam pl引 usedin this experiment werヒ asfollows: 
:'-formal cerebral tissue 28 
Normal cerebellar tissue 10 




G lioblastorna ~ 
Ependymoblastoma ’］ ） 





Pituitarv adenoma 2 
Schwannoma 
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Craniopharyngioma 
Ependymoma 
Total number of tumors 
3 Results 
1) Phosphorus contents in tumor, brain and muscle tissue 
Obtained tissues were divided into groups of cerebrum, cerebellum, muscle and various 
kinds of tumor. Amount of phosphorus was expressed as mg per gram of each tissue. 
Table 1 illustrated the mean value and the standard deviation of each groups. Amount 
of phosphorus in tumor was lower than that of normal brain and higher than that of 
muscle. Fractionated results showed that the brain tissue contained a large amount of 
phospholipid and this was the reason for a large content of phosphorus in brain tissue. 
As for the phosphorus in nucleic acid fraction, the amount was more in tumor than in 
cerebrum and equal to that of cerebellum. This may be due to the difference in cellu-
larity between cortex of cerebrum and cerebellum or tumor tissue, and also due to that 
the tumor tissue contains more nucleic acid. 
No remarkable difference was present between histologically malignant tumors and 
benign ones or glioma group and meningioma group. However, within the limit of glioma 
group, there was a tendency that the more malignant tumor contained the more phosp-
horus in every fraction. 
2) Uptake of isotope 
・when the radioactivities of these samples are to be compared, it is necessary to study 
on the value expressed as the ratio of radioactivity of tissue to that of control, or the ratio 
of radioactivity against the amount of phosphorus of the sample. Thus following three 
indices were calculated and shown in tables. 
( i ) c.p. m. ratio 
This indicates the ratio of count per minute of each sample of tumor tissue against 















Table 1 A.mount of phosphorus 
｜凶 solubleI＿山？…Ii州 m
O印土0叫l川土0吋 0.12凶叫 0服士0悶 2必M 印1[ 2 8 
i 0.670士O.l.J61.623士0.18210.413士0.1531 0.057士0.020 2.764士0.2521 10 
' 0.821 ±0.2771 0.213土0.06310.091士o.o叫 0.017土0.010 1.凶土0.3刊 10 
: 0.662±0吋 0.774士0.62710.331 ±0.1411 仙 6±0.029I 1.812±0叫 15
0.578士0.07910.475土0.05210.332士0.1631 0.059士0.033i 1.-143士o.:c2.i,




i 0.610±0.2721 0.653±0.553! 0.285土0.1691
0.740士0.2870.922土0.70010.318土0.114,
0.590土（）.QI1 0.519土0.118!0.280士0.0821
i 0山 0.0700山 0中日0叫




















( i) specific activity 
It indicates the c. p. m. per 1γof phosphorus in each sample. 
(ii) specific activity ratio 
This is thピ ratioof specific activity of tumor samples to that of control. 
The c. p. m. ratio represents the ratio of radioactivity of each fraction of the entire 
tissue, the specific activity represents the turn over rate of phosphorus of the tissue, and 
the specific activity ratio shows the comparison of this turn over rate of tumor tissue with 
that of control. Moreover, an attempt was made to deduce the grade of malignancy of 
brain tumors 0 At first, the comparison of above mentioned indices was made between well 
known malignant tumors such as metastatic carcinoma or glioblastoma and histologically 
and clinically verified benign tumors such as astrocytoma or meningioma. Then, on the 
ground of the data thus obtained, other tumors of which malignancy was not clearly known 
were studied in the same way to deduce the possible grade of malignancy. 
Tumors were divided into following groups according to the histological similarity. 
1 '.¥1eningioma group (meningioma, hemangioblastoma etc.) 
2 Glioma group 
3 Carcinoma 
4 Pituitary adenoma 
5 Schwannoma 
6 Craniopharyngioma 
They were arranged in the order of higher c. p. m. ratio in each group and shown 
in tables. Mark lこl indicates known malignant tumors，・ indicatesknown benign tumors 
andム wereput on those tumors of which malignancy is in question histologically and 
clinicalh・. 
1) First, the result in which brain tissue was taken as the control will be discussed. 
( i ) Acid soluble fraction 
Even in the cases of astrocytoma or oligodendroglioma which had the lowest c. p. m. 
ratio they showed twice as many count as control brain. In some tumors, this ratio was 
as high as 20 to 30 times. This generally accord with the tissue malignancy with ex-
ceptions of benign schwannoma or pituitary adenoma. Specific activity showed generally 
similar tendency with more exceptions. In specific activity ratio, this relationship with 
malignancy became more indi-;tinct. 
( i) Phospholipid fraction 
Table 3 showed the values of phospholipid fraction. There was parallelism of iso-
tope uptake and histological malignancy in glioma group. Specific activity ratio showed 
generally markedly high values but this was considered to be due to unusually ]ow specific 
activity of this fraction in normal brain. In brain tissue, in spite of the presence of a 
lλT貯 amountof phospholipid, P32 uptake was quite low. 
(ii) Nucleic acid fraction 
l~able 4 showed the same values of this fraction. There was a wide悶 ngeof刊 ria
ion of c. p. m. ratio from 0.7 to 1.5 of astrocytoma to 40 of gliol】lastoma. This c. p. m. 
吋 w;1"well 阿 alleledto the histo 
tendency wa弐 noted on 日pぜじificac、tivityand it、日 ratio. 
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Table 2 . ¥rnl soluble fraction 
＝－－~：三五日←－；－；；＿－ t ，姐 fal<' histological findings 一 一 一 一一一 一 一
meningioma group 
15.95 40.07 19.2 er1hr＜叫I仁 meningioma
T.N. 11.38 7.16 5.3 .ll<'lll阿川Il・ meningioma 
T.T. 8.38 Omalignant lymphoma 
治 I 6.84 8.:J:.' 3.4 e1wn11日，1cvtic mening1oma 
Y.K. 6.48 73.78 3.1 ムhemangioblasticmen川gioma(juvenile type) 
E.W. 6.15 9.23 6.6 erilm 日 ticmeningioma 
おlνl 4.62 5.19 6.4 ehemangioblastoma 
s . ¥ 3.79 2.u4 3.6 ・ll011'll日＇<i>l.l'tl meningioma (adult lvpe ! 
y K. I 2.90 17.50 3.8 e1wm111ピ，，1,1."t＇叶Jl;i
glioma group 
M.S 20.81 7.71 32.1 そpencl¥'m<JhL1st1nn<1 
YM 14.60 67.38 28.6 )glioblast《）Jl;l
トラ y 13.00 35.84 15.2 mali日rnntastrocytoma 
K.N. 12.20 26.23 I 1.1 _1!1godendr1日lioma(e問ndymoma-likepatern) 
M.Y. j 11.89 41.85 6.7 Qgiant celed glioblm,toma 
E K. 10.76 54.45 I 1.0 ：ノぞ1:iendym<1blast1ma 
M.K. 8.28 8.72 5.1 ~· lllt、du llobl出toma 
M.H. 8.14 8.79 3.7 七gliobl出 tomは
M.S i 7.06 27.73 8.0 Qglioblastoma 
T.沿 6.67 12.86 5.2 ependぅmomλ
I.H. 6.42 16.07 7.7 υl1goclt-ndrけ日lioma(ependymoma-like pattern) 
H.S -l.26 17.31 10.7 epiloid品 tr<1n・t11ma
z.o. 1.09 23.35 3.5 一 りl日udendri明lio1na
N.M. 3.47 18.42 7.7 ムastrocytoma(cerebra I) 
N.T. '..81 8.04 3.0 epiloid；阿tr川、l＜’l,1
T.H 1.90 8.69 5.~ epiloid "'tr1n・t1川旧
K.Y. 1.73 1.49 2.2 ムoligodendroglioma
carcmoπ1as 
Y.F. 15.10 10.51 6.7 me七istat1ccarcinoma 
T.M. 11.67 13.70 l.-1 .-embr、川1aI cel carcinoma 
T.K 8.41 27.06 12.5 1el<1>ょtaticcarcinoma 
H.K 7.76 21.16 9.4 •111etasL1t1c carcmo口1a
pituitary adenomas 
E.T. 24.28 16.16 13.9 .l‘l 1r• <Il< •ph• "" adenoma 
K.O. 21.93 19.40 10.J ．和、in＜’1》Iii ic adenoma 
schwannomas 
T.T. I 21.10 37.83 22.1 •-c h 、＼ '1 1111<• 11 1・ E
M.Y. 15.96 ．？、t・!l¥;lll"Ini 
K.M. 12.62 29.83 13.1 .,l・＇＂＇.111＜川l.I
T.S 12.07 30.01 8.1 ．、elm吐川1＜川1.1
ciamopharyngioma 
M.T. I 4.95 8.17 l.8 e n.11ll••pli.1n 1g1oma 
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E.T. 3~ .50 
1' () zi.93 I 
schwannomas 
T.T. i 77.71 
T 行 12.82
K .i¥.1. 8.28 
i¥.L y. I 5.40 
cra111opharyng1oma 
1¥1.T. I 6.0J ! 
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・／wrn;111gr• 山／；ト I• 河川
.ll'lil日川ticmening1oma 
er;i, ... d tl' meningioma ・lw1川町；. 1》1;.,1，川リ





































epiloid '"tro口toma ・piloidastrocytoma 
~ 、 me t a•、tatK carcmo町、a
r mct;1,t:it1c carcinoma 
r,emhryonal cel carcinoma 
me‘ta、tat1cc1 •c1n >1 111.i 
ed rr· 』 rl l • ’ph. t. adenom;i 





PHOSPHORUS UPT,-¥KEりFBRAIN TUMOR BY f¥ADIOACTIVE ISOTOPE 491 
Table 4 Nucleic acid fract10n 
じ'1＞、r I c.p. m. ratio ,. a. :;,. a. ratio I hi日tologicalfindm 
meningioma group 
T.T. 47.04 
Y.K 11.99 14.12 2.0 hemangi"hListic meningioma r .Juvenile tvpe 1 
Sλ 7.24 5.22 2.6 ef1¥,r，川1じ menin山 ima
見 I 5.2.f 1.80 1.3 e1m・11111山川ticmenin呂田ma
s .¥ ト15 8.23 7.6 e1wnw1戸i"l山、tl meningioma (adult tvpe J 
T.N. 2.88 0.81 0.7 e11wn111g< "-' t 1c meningioma 
Y.K 2.80 2.06 2.0 e1w1n111~； 1＜山 L"t'<11" 
M.M. 1.18 0.77 2.2 elwm【Il日j,,JiJ.i,tullJ 
E.W. 1.01 
glioma group 
0.69 ! 0.6 etihn川 ticmeningioma 
i¥l. y. 47.69 10.05 19.7 ~giant celled gliohl出 toma 
M.吋 13.13 2.24 11.9 Uepぞmhm"b¥a,toma 
お1 9.40 5.28 l.7 一「malignant"'tr<凡ち（（）Ind
E.K 9.32 11.91 5.9 epぞnchrrnibhトt<ima 
Z.O 8.89 3.00 1.-1 6oligodendroglioma 
K.:-.i 7.75 4.43 しO uligndendroglioma (ependymoma-like pattern) 
YM 7.58 l.87 1.3 二日liobla,torna
lvl.H 7.33 2.65 2.4 l日liobla,torna
!vi. s 6.87 l.41 2.1 Qglioblastoma 
ivl.K 4.64 1.18 6.6 Omedulloblastoma 
I .H. i 3.03 1.47 u ムoligodendroglioma(ependymoma-like pattern) 
K.Y 2.33 1.36 1.6 4与口ligodendroghoma
T.H 1.62 1.12 7.0 epiloid astrocytoma 
N.T. 1.28 1.21 3.1 epiloicl astrocytoma 
!'¥.!vi 0.80 2.76 0.7 a'tr川、tけma(cerebral) 
H.S 0.70 3.07 
2.6 .piJ，削las tr田 ytoma
carcinomas 
Y.F 228.00 3.99 3.3 meta' t,r t 1ccarcinoma 
T.K 19.42 12.12 JU meta出tatrccarcinoma 
H.K. 19.33 6.71 9.2 rneta,tat1c carcinoma 
T.M. j 2.;J4 7.36 1.4 r crnbハけnaI cel carcinoma 
p1tu1L1n・ adennrnaド
E.T 12.12 1.39 2.3 i echr"1n"ph,,¥w adenoma 
K.O 7.55 6.94 2.9 .,.,"Ill＜刊1ikadenoma 
、ι、hw,1nnornaト
T.T. I 41.31 5.40 90.0 .'L ¥¥111< <Il.I 
!vi. y 18.14 .,c¥rn;i1111' 11a 
T.S ! 12.79 4.34 17.l e,cim a日noma 
K九I ,1.38 4.08 1.2 •" ¥l¥・an< 11,r 
craniopharyng1oma 
lvl.T. 1.02 1.63 0.7 en.Ill!' 1p¥ian Iピi＇川）＼
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(iv) Phosphoprotein 
This fraction according to ScHNEIDER 's method is known to be 回 silycontaminated 
by phosphorus other than phosphoprotein. The amount of phosphorus in this fraction was 
quite litle. For these reasons, further improved and detailed technique seems to be neces-
sary for proper evaluation. Probably due to such an error in procedure, the obtained data 
showed no apparent relationship with tissue malignancy, although true evaluation of this 
fraction is left in future. 
( v ) Isotope uptake in total phosphate 
On comparison of radioactivity in each fraction, it was noted that 60 to 70% of total 
count resulted from acid soluble fraction and 20 to 25% from phospholipid fraction. There-
fore, isotope uptake was greatly dependent on that of acid soluble fraction. 
Table 5 showed the values of the total phosphate fraction and it showed the similar 
tendency to that of acid soluble fraction. 
2) Cases when muscle tissue was taken as control 
When normal brain tissue was selected as a control, the influence of blood-brain-
barrier, or the brain edema was ine¥'italコル． Therefore, for the purpose of comparison, the 
muscle tissue also was selected as a control in following cases 2 cases each of glioblastoma, 
oligodendroglioma, pituitary adenoma and schwannoma and 1 case each of medulloblastoma, 
malignant lymphoma, ependymoma and astrocytoma. 
The result was shown in Table 6. Grossly similar tendency was seen as in the回se
in which brain was taken as the control, but specific activity ratio was generally lower 
especially in phospholipid fraction. It may be justifiable to presume that this is due to 
the character of tissue component since phospholipid phosphorus in muscle is very low. 
3) Isotope uptake and histological findings 
Judging from above results, the malignancy of tumor is the most dependable on c. p. m. 
ratio especially in those of nucleic acid and acid soluble fraction. However, these fractions 
are composed of various compounds and it has been reported that the composition of these 
compounds is different in various tumors. Therefore, c. p. m. ratio of these two fractions 
only cannot be the solid ground of malignancy of tumor. However, if al the indices of 
each fraction are taken into consideration, isotope uptake of tumors of which malignancy 
is known, seems fairly well parallel to the malignancy of tumor judged on the basis of 
histological findings and clinical picture. Then those tumors of which clinical malignancy 
is not completely understood will possibly be evaluated from their isotope uptake. 
( i ) Hemangioblastic meningioma 
Among the tumors called hemangioblastic meningioma, there are two types10. One 
is called adult type and the histological picture is nearly the same as that of cerebellar 
hemangioblastoma. The other is called juvenile type and it has high cellular density and 
may be called hemangiosarcoma or undifferentiated meningioma. The latter is more fre-
quently encountered. In this series, there were one each of these types. The adult type 
was of benign form showing the similar isotope uptake in every index with cerebellar 
hemangioblastoma. Contrary to this, the juvenile type had higher value as compared with 
other tumors of meningioma group suggesting increased growth velocity. 
This finding agrees well with clinical observation. These juvenile type tumors had 
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Table 5 Total pho.;phorus 
山、e [ c.p. m. ratio I ,. a. I ,. "・ ratio [ 
meningioma group I 
S .A. 17.64 I 19.70 I 27.0 
T.T. 9コゴ ' 
T.N. I 8.81 
S. I .i 6.48 
E.W. 5.20 
y ". 5.10 
:-.; . ¥. 4.17 
M.M. 4.14 
Y.K. ; 3.48 
glioma group 
M. Y. I 14.88 





M.H. : 7.71 
M.S : 7.31 
I .H. i 6.27 
z .o. ! 4.76 
:¥.M. 3.08 
K.N. ! 2.68 
H.S. j 2.51 
T.H. 1.98 
N.T. ! 1.7-1 
K y I 1.61 
carcinomas 
Y.F. ! 21.57 
H.K. 9.12 
T.K. ・ 6.99 
T.M. 4.81 
pituitary adenomas 
E.T. I 23.92 I 
K.O. ' 20.55 I 
主chwannomas
T.T. I 28.53 
T.S. ! 12.32 
K .M 9.56 
:VI. y. 9.26 
cramopharyng1oma 
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lw11:r1gi‘小｜川i≪meningioma 1 adult type i 
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一 りIigudendroglioma ( ependymoma-1 ke pattern) 
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recurrence within 10 years in our experiences although the recurrence was not as rapid 
as sarcorr】a.
(ii) Subtype of meningioma and hemangioblastoma14> 
There was no appreciable difference in isotope uptake between fibrocytic meningioma 
and meningocytic meningioma or hemangioblastoma. 
(ii) Peculiar type ependymoma2> 
This tumor may also be called oligodendrogliomatous ependymoma. It has the 
pattern of ependymoma but major part of tumor cells is composed of oligodendrocytes. 
Two cases were encountered in this series. Their values of indices were situated between 
those of other oligodendroglioma and ependymoma. This tumor often grows to con-
siderable size but usually well demarcated from surrounding brain tissue and when totally 
removed, recurrence is rare and good prognosis can be expected. 
(iv) Glioblastoma 
In the tumors of this group, in spite of frequent presence of small necrotic foci, the 
uptake is usually much higher than astrocytoma although there was considerable variation 
in values. This may be understandable because the histological picture of this tumor is 
Table 6 
一回目 c. p. m. ratio specific act1、1t¥ratio I histology 
主L1d soluble fraction 
T.T. 7.04 ' malwmnt lymphorr,a 
M.K. 5.1 1.9 Omedulloblastoma 
FM 4.39 ;).;) gliりbl;1st＜川1'
Z.O. 1.05 5.8 _ulig叫lendrogliuma
丁目円 3.60 3.1 」よependymoma
H.N :l.2 2.9 epiloid astrocytoma 
孔l.S 2.36 3.6 c gliりblastoma
K.Y 0.43 0.7 （】1日ode1d1＜＞日lIU!ll;t 
E.T 6.69 5.7 •pituitary adenoma 
孔1.K. 4.32 •pituitary adenoma 
K入1 3.10 5.7 •'Lll\\c\llll<<lll;J 
M.Y ，ム、： 3ー巧／ .,ell＼＼.川I＜川1;
Phospholipid fraction 
l、T 16.17 ・=mah日nantl¥"lnph,m・1 
FM 335.06 16.6 Cglioblastoma 
M lく 50.89 10.6 medulloblastoma 
z .0 38.60 1.5 oligodendrり耳liomιl
r.s 18.46 13.1 epc、ndy1rn1ma
九！日 1.08 5.8 十日Iiけblastりma
H.N 8.31 2.c! epiloid astr町 ytoma
K.Y. 3.18 1.2 《1ligodenζlro日liomc1
E.T. 25.71 1.6 ep11iL1v adenoma 
M.K 14.57 epitu1tar)' adenoma 
M.¥ 379.18 ．叶l¥;JIJtl!Jfl1;1
K.M 9.68 1.9 ．叶l¥dl1Hl1l;1
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case c. p. m. rnt1<J sppecific《1ct1v1tyratio histology 
Nucleic acid fraction 
T.T. 35.10 バnalignantlymphoma 
T 討 37.62 /.'!. epenJ¥"mりma
F.M. 16.57 3.6 Qglioblastoma 
M.日 11.71 3.9 Qglioblastoma 
z.o. 11.10 J.3 '._ oligodendroghoma 
H.N 7.48 2.1 epiloid astrocytoma 
M.K. 1.69 J.0 （~＇ meJulloblastoma 
K.Y. ~.96 0.8 とoli】godenJroglioma
M.K. 24.29 •pituitary adenoma 
E.T. 8.08 1.1 .p1t111t.1ハ adenoma
Kλf 7.14 2.5 .'Lill＼，川1山川1'
恥fY. 2.49 .，じ＼1¥.lll<,ltl
Total phosphorus 
T.T. 8.55 _ malignant lymphoma 
M.K. 6.10 1.9 mιlul lりbl川tr川1'
F.M. 5.94 4.4 日¥i<Jb＼川tc1n;i
z.o. 5.17 3.6 ムoligodenclroghoma
T.S. 4.28 2A epe11dym<Jma 
H.N. 3.85 2.1 epilcnd <1'lrc川＼＜川1a
;¥IS 3.09 2.7 gliubl山 t【ima
K.Y. 0.86 0.7 <J¥i日c.:¥endrcどl1(i11a 
E.T. 7.86 ep1tc11いハ aclenoma
M.K 5.56 ep1t111t.iry adenoma 
K.M 4.05 3.1 .,,¥m;11m ,n:c 
M.Y. 3.77 .,¥l¥ill< '" 
quite variable and there are many necrotic foci which have no cellular activity. One case 
was the so-called giant celled glioblastoma, which has been said to be quite malignant. 
The uptake also supported this showing remarkably high uptake. 
( v) Cerebral astrocytoma14> 
One case was histologically diagnosed as a malignant astrocytoma. This tumor was 
composed mostly of astrocytes but had higher cellular density and occasionally bizarre cells 
were mixed. The isotope uptake of this tumor was essentially the same as that of glio『
blastoma. Contrary to this, the other cerebral astrocytoma had similar histological appea-
rance to that of cerebellar piloid astrocytoma. Also the uptake of this tumor was similar 
to that of cerebellar piloid astrocytoma. 
(vi) Schwannoma and pituitary adenoma 
These were known as benign tumors but showed high isotope uptake. The proper 
explanation to this was difficult within the limit of present experiment but there would 
be a particular phosphorus metabolism which was independent of cel division of these tumors, 
or differing from glioma, the brain tissue as a control may not be suitable to accurate 
evaluation of cell activity in these tumors. 
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Considering these facts, it may be difficult to compare glioma to these tumors on the 
same standard such as isotope uptake. 
(vii) Vascularity and cellularity of tumors 
It is quite difficult to evaluate exactly the vascularity and the cellularity of certain 
tissue. HELLERγ11 method was applied in several cases but only too erroneous results 
were obtained. Therefore, several spots of relatively homogeneous portion were selected on 
Table 7 Vasculanty and cellularity of tumors 
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histological preparation and counting of cels and vessels were done in certain microscopic 
fields. The mean value was calculated and shown in Table 7. 
No apparent tendency was found on relation of the malignancy of tumor, isotope 
uptake and cellularity or vascularity. THOMAs%l made an experimental study on intrao・
cular tumor and reported that, increased vascularity by artificial inflammation gives effect 
on isotope uptake only in the first 10 minutes after isotope injection. He also found the 
influence of vascularity on isotope uptake in variously vascularized tumors was noted only 
in the initial stage of isotope administration. Although this result is not enough to sub-
stantiate the solid decision, it can be considered that vascularity and cellularity will not 
have a large effect. 
4 Discussion 
In 1948, SELVERSTONE3oiaii administered P32 intravenously to those patients of brain 
tumor and observed the isotope concentration in tumors was 5 to 100 times as high as that 
of normal brain tissues within short period of time after administation. This concentra-
tion ratio was maintained for about two weeks. He applied this fact on the detection 
and determination of tumor localization. In 1956, he again reported32> that glioma contains 
les phospholipid than normal brain tissue and therefore, total phosphorus in glioma was 
also smaller in amount and that P32 concentration in tumor was higher in each phosphorus 
fraction especially in phospholipid fraction than that of brain tissue. Thus he concluded 
that it is due to increased cellular activity. 
The same finding was obtained in the present experiment, but c. p. m. ratio of phos-
pholipid was not quite accordant to the tumor malignancy. Therefore, high specific activity 
ratio in phospholipid fraction may be due to low specific activity of brain tissue taken as 
the control. 
There are various components in phospholipid fr汁L寸ionof brain tissue and fairly active 
P32 uptake into inositol lipid or phosphatid acid has been observed in-vivo experiment but 
the total amount of phospholipid is so large that as a whole, the specific activity may 
appear low. 
In 1952, STAPLETON34> compared P12 uptake of brain tumor to its histological findings 
and observed gross parallelism between uptake and histological malignancy of tumor. In 
this experiment, the relationship was observed more clearly in nucleic acid and acid soluble 
fraction. 
In tumor tissues, there are increased anaerobic and aerobic glucolysis and produced 
energy was used for various reactions which are essential to protein synthesis and cel 
division. Phosphorus compounds which participate in this carboll¥’dratど metabolismare 
mostlv contained in acid soluble fraction. Ther仁‘i
soluble fraction of highly malignant tumor is elevated. However, the component of thi s 
fraction is not completely clarified yet. Thus uptake of acid soluble fraction may be con-
sidered to be one of useful indices which may show the malignancv of tumor, although 
not al the components of this fraction may be directly related to the malignancv of tumors. 
The role of phospholipid and phosphoprotein in tumor tissue is also not entirely clear 
but some of these substanc巳sare known to have remarkably high metabolic activity9> 20> 2•> an. 
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In this experiment, isotope uptake of these fractions was higher than that of normal tissue 
REDDY et al231. made in-vivo experiment on ovarian tumors but he could not find any 
relationship between turnover rate of phospholipid and malignancy of tumor. On the other 
hand, ~サAKAYAM，礼21ol】ser、
of stomach, esophagus and rectum. M!ROFF et al2°1. also made in-vivo experiment on C3H 
ascites tumor and observed some relationship between relati\'t~ specific activity of tumor and 
velocity of tumor growth. However, the true role of phospholipid and phosphoprotein 
metabolism stil remained unknown. 
Contrarv to this, various studies have been made on nucleic acid metabolism and the 
tumor growth10112>18>2•＞川町 271. It is well known that DNA and RNA in nucleic acid 
fraction play important roles in protein synthesis. MIROFF et a!2°>. reported that the loga-
rithm of tumor growth velocity and that of relative specific activity of nucleic acid showed 
parallel relationship in C3H 川 citestumor. Many scholars such as NAKAYAMA21>, HAR-
RJNGTON121, REDDY et al23>, M.¥NN et al19>. and ScHNEJDER et al25>25>2n al reported the 
increased nucleic acid metabolism in tumor ti自sue. In this experiment, no further attempt 
to divide the nucleic acid component was made, but major portion of this fraction is corn-
posed of D'.¥iA and R'.¥iA which dirぜctlyparticipate in the cel division. Thus it is easily 
understandable that isotope uptake of nucleic acid fraction fairly well accords with the 
malignancy of tissue. 
The amount of phosphorus was similar to that appeared in SELVERSTONE's32> report. 
BoDJAN and Dz1EWATKOWSKJ161 made a study on monkey brain and the result appeared 
similar to this experiment. But these values in human brain was considerably lower than 
that of dog brain reported by LOGAN161 or that of rat brain by ScHNEJDER26l. However, 
the proportion of each fraction was similar to the rnse of human. 
ScHNEIDER26> reported slight increase of phosphorus contents of acid soluble fraction 
in experimental tumor but no great difference was present between various tumors. 
As for the phosholipid, ScHNEIDER261 reported no difference in amount of ph侶 phorus
in various tumors of rat. The nucleic acid phosphrous was generally increased in tumor 
tissue. ふi'HNEIDERγ5> determination on expげ imentaltumor showed considerable similarity 
of the amount of R'.¥iA and DNA in various tumors but there was considerable difference 
in various normal tissues. 川Ithese tendencies were similarly observed in this experiment. 
5 Summary 
1) Radioactive P32 was administered to 37 patients of intracranial tumor and a 
comparati吋 studywas made over isotope uptake and histological and clinical malignancy 
of tumors from the view-point of growth activity. 
2) The parallelism between isotope uptake and malignanc‘y of tissue was most clearly 
noted in c. p. m. ratio of nucleic acid fraction followed by that of acid soluble fraction. 
Specific act i \· it~· also showed similar tendenc＼ア
f 3) The result of this experiment revealed that it is not proper to compare the dif-
吋ntr削 uredtumors such zis meningioma, glioma, carcinoma, schwannoma or pituitary 
adenorna on the same standard of isotorた uptake But P32 uptake showed fairly good 
parallel relationship with malignancy of tumor when compared within the groups of glioma 
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or menmgioma. 
4) Three indices on P32 uptake were proposed. The discussion was made on such 
tumors出 hemangioblasticmeningioma, peculiar type ependymoma or cerebral astrocytoma 
judged according to these indices. The clinical course of these tumors well accorded with 
the velocity of tumor growth when judged in this manner. 
5) Phosphorus content was much greater in normal brain tissue than in tumor tissue 
and this is mainly due to phospholipid which is contained in brain tissue in large amount. 
The phosphorus in nucleic acid or in acid soluble fraction was rather more in tumor tissue. 
Markedly high specific activity ratio of phospholipid of brain tumor may not be due to 
high metabolic rate of this fraction but due to remarkably low specific activity of this 
fraction in brain tissue. 
6) No relationship was found between P32 11ptake and vascularity or cellular density 
of tumors. 
7) Results were compared when brain tissue was taken as a control and when muscle 
was taken each other. As for the relationship between P32 uptake and malignancy of 
tumor, there was no remarkable difference. 
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3) p3c摂取量の上からp カウント比p 比活性度，
比活性度率等を J,k準とし，明らかに悪性である Gliり
bL"tomaや良性であるふtrocytoma等に対しF 悪性度が
充分明らかでない幾つかの腫疹を対比させて見るとp
その結果は臨床吋過にかなりよく適合し，それ等の腫
疹の性格をある程度理解するのに有用であった．
4) 対照組織には脳及び筋肉組織を用いた才勺 二h
等2つの場合には著明な差は認められなかった．
5) 燐含有量は種疹組織よりも脳組織に多かった
が，これは脳には大量の燐脂質が含まれる放でありp
核酸及び酸可溶性分画の燐はむしろ腫疹に多かった．
脳暖疹においては脳を対照とするとき，燐脂質分l亜の
比活性度率が非常に高かった，h，これは脳のこの分爵
の比活性度が非常に低かったためでP この分画の代謝
が特に高かったためとは考え難い．
6) p32疾取量と組織の細胞密度や血管分布の聞に
は一定の関係が見出せなかった．
